Open AccessDICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric Oncology
Author(s) -
Kelly M. Bailey,
Michelle F. Jacobs,
Bailey Anderson,
Raja Rabah,
YiMi Wu,
Tobias Else,
Rajen Mody
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00172
Subject(s) - exome sequencing , dna sequencing , deep sequencing , exome , medicine , germline , germline mutation , bioinformatics , genetics , mutation , biology , genome , gene
DICER1 syndrome is a recently described inherited cancer predisposition syndrome caused by pathogenic variants in DICER1 . With the recent increase in integrative clinical sequencing for pediatric patients with cancer, our understanding of the DICER1 syndrome continues to evolve, as new and rare pathogenic variants are reported. As the frequency of integrative clinical sequencing increases, discussions regarding challenges encountered in the interpretation of sequencing results are essential to continue to advance the field of cancer predisposition. The purpose of this work was to identify patients with somatic and/or germline DICER1 variants in our patient population and to discuss sequencing interpretation and the clinical recommendations that result from the integrative clinical sequencing results.